Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
US
INT
DA
DE
FR
SV
Main menu button
Team
Deals
Contact
Team
Deals
Contact
Back to News
Carlsquare Equity Research interview with Biosergen
Equity Research
7 Mar 2024
Share
Tweet
Share
Herman Kuntscher
Equity Analyst
+46 70 585 99 32
herman.kuntscher@carlsquare.com
Niklas Elmhammer
Senior Equity Analyst
+46 70 898 39 59
niklas.elmhammer@carlsquare.com
Similar News
02 Jul 2025
Equity research Immunovia: PancreaSure test achieves CPT code assignment
Equity Research
Immunovia
02 Jul 2025
Equity Research ALM Equity, Q2 2025: More housing starts are expected in the second half of the year
Equity Research
ALM Equity
01 Jul 2025
Equity Research KlaraBo, Q2 2025: Should benefit from lower interest rates
Equity Research
KlaraBo
30 Jun 2025
Equity research CDON, Q2 2025: We expect a small step forward
Equity Research
CDON
17 Jun 2025
Equity Research Svenska Aerogel: Delivery of 2.6 tons Quartzene® completed
Equity Research
Svenska Aerogel